Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -18.51% is 59% above its 5-year average of -45.50%, near the high end of its 5-year range (-129.61%–-18.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.16% above its 12-month average of -25.76%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -18.51%.
RETURN ON INVESTED CAPITAL (ROIC)
-18.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-25.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-41.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-45.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.16%
CURRENT VS 3Y AVG
+55.12%
CURRENT VS 5Y AVG
+59.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+48.10%
vs the sector median at left
Trevi Therapeutics, Inc.
Market Cap
$1.87B
Return on Invested Capital (ROIC)
-18.51%
TTM Avg
-25.76%
3Y Avg
-41.24%
5Y Avg
-45.50%
Market Cap
$1.86B
Return on Invested Capital (ROIC)
-36.37%
TTM Avg
8.48%
3Y Avg
-213.38%
5Y Avg
-299.96%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
1.72%
TTM Avg
-1.08%
3Y Avg
-2.19%
5Y Avg
-2.71%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
-44.06%
TTM Avg
-33.50%
3Y Avg
-17.90%
5Y Avg
-30.16%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
-44.21%
TTM Avg
-32.05%
3Y Avg
-35.56%
5Y Avg
-35.59%
Market Cap
$1.85B
Return on Invested Capital (ROIC)
-51.06%
TTM Avg
-99.01%
3Y Avg
-126.31%
5Y Avg
-97.79%
Market Cap
$1.84B
Return on Invested Capital (ROIC)
-23.90%
TTM Avg
-49.28%
3Y Avg
-183.01%
5Y Avg
-156.37%
Market Cap
$1.83B
Return on Invested Capital (ROIC)
4.13%
TTM Avg
4.21%
3Y Avg
5.71%
5Y Avg
5.17%
Market Cap
$1.83B
Return on Invested Capital (ROIC)
-5.33%
TTM Avg
-11.54%
3Y Avg
-13.58%
5Y Avg
-15.53%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. (TRVI) | $1.87B | -18.51% | -25.76% | -41.24% | -45.50% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -36.37% | 8.48% | -213.38% | -299.96% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 1.72% | -1.08% | -2.19% | -2.71% |
| Zymeworks Inc. (ZYME)vs › | $1.89B | -44.06% | -33.50% | -17.90% | -30.16% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -44.21% | -32.05% | -35.56% | -35.59% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -51.06% | -99.01% | -126.31% | -97.79% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | -23.90% | -49.28% | -183.01% | -156.37% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 4.13% | 4.21% | 5.71% | 5.17% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -5.33% | -11.54% | -13.58% | -15.53% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | -6.53% | -15.76% | -21.33% | -21.68% |
ROIC
-18.5%
ROE
-15.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -18.51% |
| 2026-03-31 | -30.59% |
| 2025-12-31 | -26.85% |
| 2025-09-30 | -26.98% |
| 2025-06-30 | -25.88% |
| 2025-03-31 | -51.02% |
| 2024-12-31 | -51.32% |
| 2024-09-30 | -80.65% |
| 2024-06-30 | -64.38% |
| 2024-03-31 | -52.22% |
| 2023-12-31 | -40.59% |
| 2023-09-30 | -34.88% |
| 2023-06-30 | -32.21% |
| 2023-03-31 | -27.56% |
| 2022-12-31 | -25.65% |
| 2022-09-30 | -26.11% |
| 2022-06-30 | -41.20% |
| 2022-03-31 | -128.11% |
| 2021-12-31 | -102.82% |
| 2021-09-30 | -129.61% |
| 2021-06-30 | -105.05% |
| 2021-03-31 | -83.57% |
| 2020-12-31 | -78.14% |
| 2020-09-30 | -60.39% |
| 2020-06-30 | -75.72% |
| 2020-03-31 | -64.65% |
| 2019-12-31 | -48.62% |
| 2019-09-30 | -42.31% |
| 2019-06-30 | -33.99% |
| 2019-03-31 | -148.51% |
| 2018-12-31 | -103.34% |
| 2018-09-30 | -109.28% |
